Trichuriasis
11
2
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
67%
6 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (11)
Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC
A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura
Efficacy and Safety of IVM/ALB Co-administration
Efficacy and Safety of MOX/ALB Co-administration
Albendazole Dose Finding and Pharmacokinetics in Children and Adults
Efficacy Albendazole and Levamisole Against STH on Unguja
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections